These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7057343)

  • 1. Plasma cysteamine concentrations in children treated for cystinosis.
    Jonas AJ; Schneider JA
    J Pediatr; 1982 Feb; 100(2):321-3. PubMed ID: 7057343
    [No Abstract]   [Full Text] [Related]  

  • 2. Cysteamine therapy for cystinosis.
    Roy LP; Pollard AC
    Lancet; 1978 Sep; 2(8092 Pt 1):729-30. PubMed ID: 80647
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis.
    Smolin LA; Clark KF; Thoene JG; Gahl WA; Schneider JA
    Pediatr Res; 1988 Jun; 23(6):616-20. PubMed ID: 3393396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral phosphocysteamine and rectal cysteamine in cystinosis.
    van't Hoff WG; Baker T; Dalton RN; Duke LC; Smith SP; Chantler C; Haycock GB
    Arch Dis Child; 1991 Dec; 66(12):1434-7. PubMed ID: 1776892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine.
    Gahl WA; Schneider JA; Schulman JD; Thoene JG; Reed GF
    Pediatr Nephrol; 1990 Mar; 4(2):129-35. PubMed ID: 2397178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of cystinosis using cysteamine].
    Broyer M; Tete MJ
    Ann Pediatr (Paris); 1990 Feb; 37(2):91-3. PubMed ID: 2321906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cysteamine in the treatment of cystinosis in children. In vitro and in vivo studies].
    Louis JJ; Guibaud P; Dumoulin R; Parchoux B; Zabot MT; Bureau J; Baltassat P; Frederich A; Larbre F
    Pediatrie; 1984 Dec; 39(8):619-33. PubMed ID: 6535971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intra-leukocyte cystine in cystinosis treated with cysteamine].
    Ged C; Jean G; Tete MJ; Broyer M; Kamoun P
    Ann Biol Clin (Paris); 1991; 49(9):482-6. PubMed ID: 1789502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negligible urinary cysteamine loss in cystinosis patients with Fanconi syndrome.
    Levtchenko EN; de Graaf-Hess A; Blom HJ; Monnens LA
    Clin Nephrol; 2002 May; 57(5):349-51. PubMed ID: 12036193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of cystinosis in children with twice-daily cysteamine.
    Dohil R; Gangoiti JA; Cabrera BL; Fidler M; Schneider JA; Barshop BA
    J Pediatr; 2010 May; 156(5):823-7. PubMed ID: 20138296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cystine determination in mixed leukocytes vs polymorphonuclear leukocytes for diagnosis of cystinosis and monitoring of cysteamine therapy.
    Levtchenko E; de Graaf-Hess A; Wilmer M; van den Heuvel L; Monnens L; Blom H
    Clin Chem; 2004 Sep; 50(9):1686-8. PubMed ID: 15331510
    [No Abstract]   [Full Text] [Related]  

  • 12. Twice-daily cysteamine bitartrate therapy for children with cystinosis.
    Dohil R; Fidler M; Gangoiti JA; Kaskel F; Schneider JA; Barshop BA
    J Pediatr; 2010 Jan; 156(1):71-75.e1-3. PubMed ID: 19775699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteamine therapy for children with nephropathic cystinosis.
    Gahl WA; Reed GF; Thoene JG; Schulman JD; Rizzo WB; Jonas AJ; Denman DW; Schlesselman JJ; Corden BJ; Schneider JA
    N Engl J Med; 1987 Apr; 316(16):971-7. PubMed ID: 3550461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
    Nesterova G; Williams C; Bernardini I; Gahl WA
    Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding intestinal cysteamine bitartrate absorption.
    Dohil R; Fidler M; Barshop BA; Gangoiti J; Deutsch R; Martin M; Schneider JA
    J Pediatr; 2006 Jun; 148(6):764-9. PubMed ID: 16769383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.
    Ahlenstiel-Grunow T; Kanzelmeyer NK; Froede K; Kreuzer M; Drube J; Lerch C; Pape L
    Pediatr Nephrol; 2017 Jan; 32(1):91-97. PubMed ID: 27350621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of infantile nephropathic cystinosis with cysteamine.
    da Silva VA; Zurbrügg RP; Lavanchy P; Blumberg A; Suter H; Wyss SR; Lüthy CM; Oetliker OH
    N Engl J Med; 1985 Dec; 313(23):1460-3. PubMed ID: 4058549
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of cysteamine therapy in nephropathic cystinosis.
    Yudkoff M; Foreman JW; Segal S
    N Engl J Med; 1981 Jan; 304(3):141-5. PubMed ID: 7442733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blunted prolactin response to thyrotropin-releasing hormone stimulation in cystinotic children receiving cysteamine.
    Gahl WA; Bercu BB
    J Clin Endocrinol Metab; 1985 Apr; 60(4):793-6. PubMed ID: 3919054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cysteamine eyedrops for treatment of corneal cysteine deposits in infantile cystinosis].
    Gräf M; Grote A; Wagner F
    Klin Monbl Augenheilkd; 1992 Jul; 201(1):48-50. PubMed ID: 1513127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.